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Research
We recently reported high concentrations 
of lithium, arsenic, cesium, rubidium, and 
boron in groundwater in the Puna region in 
the Argentinean Andes, probably related to 
influence of thermal water on the drinking 
water source (Concha et al. 2010). Similar 
lithium concentrations in drinking water (e.g., 
1–3 mg/L) have been reported from northern 
Chile (Barr et al. 1993), but little is known 
about the prevalence and geographic distribu-
tion of lithium in drinking water in general. 
A study of trace elements in 132 brands of 
bottled water from 28 countries reported a 
median lithium concentration of 4.8 μg/L, 
with a total range of 0.06–5,460 μg/L 
(Krachler and Shotyk 2009), suggesting that 
the findings in Argentina and Chile are not 
unique. However, there appears to be neither 
drinking water standards nor risk assessments 
for lithium in drinking water.
The highest levels of lithium in drink-
ing water in the Puna region were detected 
in the village of San Antonio de Los Cobres 
(1,005 μg/L; Concha et al. 2010), with little 
variation over the period meas  ured (years 
2004–2008). If we assume a stable exposure, 
the urinary lithium concentrations in women 
from San Antonio de los Cobres suggests a 
total daily lithium intake of 2–30 mg, includ-
ing 2–3 mg from drinking water (Concha et al. 
2010). For a woman weighing 50 kg, this level 
of exposure is within an order of magnitude of 
lithium doses used for maintenance treatment 
of bipolar disorder, 1–5 mg lithium/kg body 
weight/day (Grandjean and Aubry 2009a). 
Major side effects of long-term lithium ther-
apy include thyroid abnormalities (presenting 
mainly as hypothyroidism and goiter), weight 
gain, edema, gastro  intestinal pain, diarrhea, 
tremor, polyuria, and renal tubular damage 
(Aral and Vecchio-Sadus 2008; Grandjean and 
Aubry 2009b). Because of these well-  recognized 
effects of lithium treatment, we wanted to 
evaluate potential effects of chronic exposure 
to lithium through drinking water and other 
environ  mental sources. We recruited women in 
a number of Puna villages in the Argentinean 
Andes with a wide range of lithium concentra-
tions in drinking water supplies (8–1,005 μg/L; 
Concha et al. 2010) and evaluated the poten-
tial impact of urinary lithium on the con-
centrations of free thyroxine (T4) and the 
pituitary gland hormone thyrotropin [thyroid- 
stimulating hormone (TSH)] in plasma. 
We also evaluated associations between uri-
nary lithium concentration and body mass 
index (BMI).
Materials and Methods
Study site and subjects. The Puna is the 
arid part of the Andean Mountains in 
northern Argentina, at an altitude around 
3,000–4,000 m. Most study participants 
(n = 161) were from the village of San 
Antonio de los Cobres, province of Salta, 
with about 5,000 inhabitants, mainly of 
indigenous origin (Concha et al. 2010). 
Additional participants lived in the small 
Puna communities Olacapato (n = 14), 
Salar de Pocitos (n = 5), and Tolar Grande 
(n = 22), located 60–187 km southwest and 
west of San Antonio de los Cobres and each 
with < 200 inhabitants. In each village, all 
individuals had drinking water from the same 
source, with small variations in element con-
centrations over time (Concha et al. 2010).
Element concentrations in drinking water 
from different sources vary greatly within 
short geographic distances, mainly because of 
the presence of volcanic bedrock. Therefore, 
long-term exposure to lithium is difficult to 
assess for people not living most of the time 
in a defined area, where information about 
levels in drinking water is available. Thus, 
in the present study we focused on women 
because they spend more time close to home 
than do men, who may work outside the 
monitored region (e.g., in the city of Salta or 
in Chile) for long periods of time.
In San Antonio de los Cobres, women 
were recruited by physicians and community 
health workers at the local hospital. In the 
other villages, women were recruited with the 
assistance of personnel at local health centers 
or during visits to homes of village inhabit-
ants. Although it was not possible, for practi-
cal reasons, to select the women at random, 
the community health workers at the hospital 
and health centers tried to recruit women 
from the whole district, to get as wide a geo-
graphic distribution of households as possible. 
There were no inclusion/exclusion criteria for 
study participation other than sex. No chil-
dren < 12 years of age were recruited. The 
women were interviewed about what kind of 
Address correspondence to K. Broberg, Lund University, 
Division of Occupational and Environmental Medicine, 
Klinikgatan 21, SE-221 85 Lund, Sweden. Telephone: 
46-46-173819. Fax: 46-46-143702. E-mail: karin.
broberg@med.lu.se
Supplemental Material is available online (doi:10. 
1289/ehp.1002678 via http://dx.doi.org/).
We thank A. Cardozo, P. Mamaní, E. Casimiro, 
and E. Assarsson for recruiting the volunteers. 
This study was supported by the Swedish Council 
for Working Life and Social Research, the European 
Union within the Sixth Framework Programme for 
Research and Technological Development (“PHIME” 
contract FOOD-CT-2006-016253), and the Kungliga 
Fysiografiska Sällskapet.
The authors declare they have no actual or potential 
competing   financial interests.
Received 5 July 2010; accepted 20 January 2010.
Lithium in Drinking Water and Thyroid Function
Karin Broberg,1 Gabriela Concha,2 Karin Engström,1 Magnus Lindvall,3 Margareta Grandér,4 and Marie Vahter4
1Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden; 2Division of Toxicology, Swedish National 
Food Administration, Uppsala, Sweden; 3Department of Child and Youth Psychiatry, Lund University, Lund, Sweden; 4Institute of 
Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Ba c k g r o u n d: High concentrations of lithium in drinking water were previously discovered in the 
Argentinean Andes Mountains. Lithium is used worldwide for treatment of bipolar disorder and 
treatment-resistant depression. One known side effect is altered thyroid function.
oBjectives: We assessed associations between exposure to lithium from drinking water and other 
environmental sources and thyroid function.
Me t h o d s : Women (n = 202) were recruited in four Andean villages in northern Argentina. Lithium 
exposure was assessed based on concentrations in spot urine samples, measured by inductively cou-
pled plasma mass spectrometry. Thyroid function was evaluated by plasma free thyroxine (T4) and 
pituitary gland thyroid-stimulating hormone (TSH), analyzed by routine immuno  metric methods.
re s u l t s: The median urinary lithium concentration was 3,910 μg/L (5th, 95th percentiles, 
270 μg/L, 10,400 μg/L). Median plasma concentrations (5th, 95th percentiles) of T4 and TSH were 
17 pmol/L (13 pmol/L, 21 pmol/L) and 1.9 mIU/L, (0.68 mIU/L, 4.9 mIU/L), respectively. Urine 
lithium was inversely associated with T4 [β for a 1,000-μg/L increase = –0.19; 95% confidence 
interval (CI), –0.31 to –0.068; p = 0.002] and positively associated with TSH (β = 0.096; 95% CI, 
0.033 to 0.16; p = 0.003). Both associations persisted after adjustment (for T4, β = –0.17; 95% 
CI, –0.32 to –0.015; p = 0.032; for TSH: β = 0.089; 95% CI, 0.024 to 0.15; p = 0.007). Urine 
selenium was positively associated with T4 (adjusted T4 for a 1 μg/L increase: β = 0.041; 95% CI, 
0.012 to 0.071; p = 0.006).
co n c l u s i o n s: Exposure to lithium via drinking water and other environmental sources may affect 
thyroid function, consistent with known side effects of medical treatment with lithium. This stresses 
the need to screen for lithium in all drinking water sources.
Key w o r d s : bipolar disorder, iodine, lithium, selenium, thyroid-stimulating hormone, thyroxine. 
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water they consumed (tap water/bottled water 
and source of the tap water), their dietary 
habits (what do you eat for breakfast, lunch, 
and dinner?), diseases, and time of residence 
in the area, including that of their parents and 
grandparents. These questions revealed that 
all women almost exclusively drank tap water, 
their diets (mainly corn, beans, chicken, and 
pork) were very similar, and only 3 of 202 
women reported ongoing use of any medica-
tion: One was being treated for gastritis and 
two for high blood pressure. Their time of 
residence in the area and other charac  teristics 
are presented in Table 1. Height and weight 
were measured using standardized protocols, 
and the women were asked to donate a urine 
sample (~ 20 mL) and blood samples (4 mL 
for separation of plasma). All the samples 
were collected at the hospital or the local 
health clinics during the daytime, and study 
participants were allowed to eat and drink 
before sampling. All the volunteers gave oral 
and written consent. The study was approved 
by the Ministry of Health in Salta, Argentina, 
and the ethical committee at Karolinska 
Institute (Sweden).
Sample collection. Spot-urine samples 
were collected in disposable paper cups and 
immediately transferred to 20-mL acid-washed 
polyethylene bottles. After testing for pH and 
presence of protein and glucose by urine test 
strips (Siemens Multistix, Tarrytown, NY, 
USA), the urine samples were frozen at –20°C. 
Markers of thyroid function were measured 
in plasma, which was obtained from collected 
venous blood samples (heparin tubes) that 
were centrifuged within 10 min after blood 
withdrawal. Plasma and urine samples were 
kept at –20°C until they were transported 
(with cooling blocks) to Sweden for analysis.
Analysis of elements and markers of thy-
roid function. We evaluated arsenic, boron, 
and cesium in urine because our previous 
study had demon  strated that these elements 
were elevated in drinking water in the same 
regions as lithium (Concha et al. 2010). Of 
note, cesium is known to accumulate in the 
thyroid (Bandazhevsky 2003). We also evalu-
ated selenium and iodine because these ele-
ments are important for thyroid function 
[Lu and Holmgren 2009; World Health 
Organization (WHO) et al. 2007]. The uri-
nary samples were analyzed 3 months after 
sampling using inductively coupled plasma 
mass spectrometry with collision/reaction 
cell (Agilent 7500ce; Agilent Technologies, 
Waldbronn, Germany) as described previously 
(Concha et al. 2010). Iodine was measured 
after diluting the urine with 0.1% NH4OH 
(Suprapur; Merck, Darmstadt, Germany). 
Analytical accuracy was ascertained by analyz-
ing commercially available urine reference 
materials (Concha et al. 2010). For iodine, we 
analyzed Seronorm Urine No. 2525 (refer-
ence value, 282 μg/L) and OK4636 (analyti-
cal value, 139 μg/L; SERO AS, Billingstad, 
Norway) and obtained measured values 
of 294 ± 7.5 and 133 ± 4.4 μg/L (n = 11), 
respectively. To compensate for dilution, we 
Table 2. Association between a 1,000-μg/L increase in urine lithium 
  concentration and markers of thyroid function and BMI by linear regression 
analysis.a 
Outcome β-Coefficient 95% CI p-Value
T4
Unadjusted –0.19 –0.31 to –0.068 0.002
Adjustedb –0.17 –0.32 to –0.015 0.032
TSH
Unadjusted 0.096 0.033 to 0.16 0.003
Adjustedc 0.089 0.024 to 0.15 0.007
BMI
Unadjusted 0.18 –0.039 to 0.40 0.11
Adjustedd 0.14 –0.059 to 0.35 0.16
aAdjusted models include covariates with p < 0.25 in a univariate analysis, apart from 
boron, which was highly correlated to lithium (rs = 0.85; p = 0.001). bAdjusted for urinary 
arsenic, cesium, and selenium; age; parity; and BMI. cAdjusted for selenium and BMI. 
dAdjusted for urinary iodine, age, and parity. 
Figure 1. Association between urinary lithium concentration and plasma free T4. 
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Table 1. Characteristics, measured concentrations of elements and hormones in urine and plasma, and correlations between the variables and T4 and TSH (n = 202).a 
5th, 95th 
percentiles Minimum–maximum
Spearman rank (rs) correlation
Variable Mean Median T4 TSH
Age (years) 37.2 34 18, 64 12–80 –0.19** –0.048
Years living in the area 24.7 25 3, 51 0.3–71 –0.096 –0.012
BMI (kg/m2) 25.6 24.7 18.8, 35 16–40 –0.24** 0.063
Parity (n) 4.3 3 0, 11 0–14 –0.28# –0.064
Urinary concentration (μg/L)
Lithium 4,404 3,914 268, 10,392 117–14,343 –0.25** 0.10
Boron 15,000 14,578 2,602, 27,907 1,292–45,313 –0.024** 0.025
Arsenic 244 230 21, 545 10–1,250 –0.20** 0.002
Cesium 473 470 26, 880 8.0–2,243 –0.27# –0.005
Selenium 28 25 11, 51 4.0–74 0.23** –0.18*
Iodine 147 125 37, 354 16–857 0.035 –0.063
Plasma concentration
T4 (pmol/L) 17 17 13, 21 11–32 — –0.11
TSH (mIU/L) 2.2 1.9 0.68, 4.9 0–8.8 –0.11 —
aAll values were based on 202 observations with the exception of years living in the area (n = 198), parity (n = 197), plasma T4 (n = 194), and TSH (n = 196), because of either missing 
information (years living in the area and parity) or insufficient amount of sample left for analysis (plasma T4 and TSH). *p < 0.05, **p < 0.01, and #p < 0.001, for the Spearman’s correla-
tions between the variables and T4 and TSH.Lithium in drinking water and thyroid function
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meas  ured specific gravity of urine using a 
digital refractometer (EUROMEX RD 712 
clinical refractometer; EUROMEX, Arnhem, 
the Netherlands), and adjusted meas  ured 
analyte concentrations to the mean specific 
gravity of all samples (1.020 g/mL). Free T4 
and TSH were measured in 100 μL plasma 
by an immuno  metric method with reagents 
from Roche Diagnostics (Mannheim, 
Germany), performed as a routine analysis at 
the Department of Clinical Chemistry, Lund 
University. All plasma samples were stored for 
approximately 1 year at –20°C before analysis 
of T4 and TSH. According to the literature 
(El Ezzi et al. 2010; Männistö et al. 2007), 
the concentrations of T4 and TSH are very 
stable over time. 
Statistical analysis. We calculated the 
associations between charac  teristics of study 
subjects, urinary concentrations of selected 
elements, and plasma T4 and TSH levels 
using the Spearman correlation coefficient 
(rs). Associations between markers of thyroid 
function and BMI (dependent variables) and 
the selected elements, age, and parity (inde-
pendent variables) were first analyzed with 
univariate linear regression analysis. Then 
multi  variate models were used to estimate 
associations between urinary lithium concen-
tration and T4, TSH, and BMI adjusted for 
other influential variables (defined as inde-
pendent variables with p-values < 0.25 in the 
univariate linear regression analysis). Potential 
influential variables were the elements arse-
nic, boron, and cesium, which are elevated in 
drinking water in the same regions as lithium; 
and age, parity, and BMI because these factors 
may influence the markers of thyroid func-
tion. All statistical analyses were performed 
using IBM SPSS Statistics (version 18.0; SPSS 
Inc., Chicago, IL, USA). Associations were 
considered statistically significant based on an 
alpha level of 0.05.
Results
Study participants had a median age 
of 34 years and parity of three children 
(Table 1). The median BMI was 24.7 kg/
m2 (in the upper range of normal weight, 
18.5–24.99 kg/m2), and 17% of the women 
(n = 35) were considered obese (> 30 kg/m2). 
T4 values were outside of the normal range 
(12–22 pmol/L) in 5 (2.6%) of 194 women 
(1 below and 4 above normal range), and 
TSH values were outside the normal range 
(0.4–4.0 mIE/L) in 20 (10%) of 196 women 
(3 below and 17 above normal range). Ninety-
seven percent of the women reported that 
they had lived > 2 years in the area. Table 1 
also shows the concentrations of toxic and 
essential elements in urine. 
Lithium, boron, arsenic, and cesium in 
urine were all negatively correlated to free T4 
(Table 1), but we found no significant cor-
relations between these elements and TSH. 
Selenium, but not iodine, in urine was posi-
tively correlated to T4 and inversely correlated 
to TSH. Age, BMI, and parity were all nega-
tively associated with T4 but not with TSH. 
We found a negative correlation between 
reported number of ingested glasses of water 
per day and TSH (rs = –0.17; p = 0.015), but 
water consumption was not correlated with 
T4 (p = 0.36).
Urine lithium concentration was inversely 
associated with free T4 before and after adjust-
ment [Table 2, Figure 1; adjusted β for a 
1,000-μg/L increase in urinary lithium con-
centration = 0.17; 95% confidence interval 
(CI), –0.32 to –0.015; p = 0.032] and posi-
tively associated with TSH (Table 2, Figure 2; 
adjusted β = 0.089; 95% CI, 0.024 to 0.15; 
p = 0.007). The effect of lithium on TSH 
was still present when we adjusted for arsenic, 
cesium, selenium, iodine, age, parity, and BMI 
(β = 0.14; 95% CI, 0.054 to 0.022; p = 0.001). 
For comparison, the β-coefficient point 
estimates for the associations between other 
covariates and markers of thyroid function 
and BMI are shown in Supplemental Material, 
Table 1 (doi:10.1289/ehp.1002678). Estimates 
were similar when we limited multi  variate 
analyses to women who had lived > 2 years 
in the area (n = 179–180; for T4, β = –0.17; 
95% CI, –0.32 to –0.011; p = 0.036; for TSH: 
β = 0.15; 95% CI, 0.063 to 0.23; p = 0.001). 
We found no association between lithium and 
T4 or TSH values outside the normal range 
(data not shown).
We found a non  significant positive asso-
ciation between urinary lithium and BMI 
(Table 2, Figure 3). The association between 
lithum and BMI became less significant 
after additional adjustment for T4 and TSH 
(β = 0.068; 95% CI, –0.015 to 0.28; p = 0.53).
In contrast with lithium, urinary selenium 
was positively associated with T4 (unadjusted 
β for a 1-μg/L increase in selenium = 0.05; 
95% CI, 0.022 to 0.078; p = 0.001) and 
inversely associated with TSH (β = –0.014; 
95% CI, –0.029 to 0.001; p = 0.069). However, 
only the association with T4 was statistically 
significant after adjustments [see Supplemental 
Material, Table 1 (doi:10.1289/ehp.1002678)]. 
Urinary boron was significantly nega-
tively associated with T4 (β for a 1,000 μg/L 
increase = –0.068; 95% CI, –0.11 to –0.025; 
p = 0.002) but was not associated with TSH in 
uni  variate analyses. However, because of high 
collinearity (rs = 0.85; p < 0.001) between boron 
and lithium, we did not include boron in multi-
variate analyses of associations between lithium 
and T4, TSH, or BMI. When boron was mod-
eled instead of lithium in a multi  variate analy-
sis, we found no association between boron and 
TSH or BMI (p = 0.34 and p = 0.48) but it was 
inversely associated with T4 (β = –0.075; 95% 
CI, –0.14 to –0.013; p = 0.018). Cesium and 
arsenic were not associated with T4 or TSH (see 
Supplemental Material, Table 1).
Figure 2. Association between urinary lithium concentration and plasma TSH.
14,000 12,000 10,000 8,000 6,000 4,000 2,000 0
P
l
a
s
m
a
 
T
S
H
 
(
m
I
U
/
L
)
10
8
6
4
2
0
Lithium (μg/L)
Figure 3. Association between urinary lithium concentration and BMI.
14,000 12,000 10,000 8,000 6,000 4,000 2,000 0
B
M
I
 
(
k
g
/
m
2
)
40
35
30
25
20
15
Lithium (μg/L)Broberg et al.
830  v o l u m e  119 | n u m b e r 6 | June 2011  •  Environmental Health Perspectives
Discussion
This is to our knowledge the first study 
investigating the potential health impact of 
long-term lithium exposure from drinking 
water and other environmental sources on the 
thyroid. We found an association between 
lithium exposure, as assessed by lithium con-
centrations in urine, and markers of thyroid 
function. The positive associations between 
lithium and TSH and the inverse association 
between lithium and T4 are consistent with 
reports of hypothyroidism as a side effect of 
chronic use of lithium medication (Grandjean 
and Aubry 2009b; Lazarus 2009). Lithium 
treatment is also associated with weight gain 
(Grandjean and Aubry 2009b); however, we 
noted only a small, non  significant association 
between urinary lithium concentration and 
BMI in our study population. The positive 
association with T4 and inverse association 
with TSH suggest that selenium may have 
had a beneficial effect on thyroid function in 
this population, but, contrary to expectations, 
we did not observe similar associations with 
iodine. Cesium was not associated with T4 or 
TSH, despite accumulation of cesium in the 
thyroid (Bandazhevsky 2003).
The main strength of our study is the use 
of a biomarker of lithium exposure in urine 
combined with analysis of biomarkers for sele-
nium, iodine, and cesium—all elements that 
may influence thyroid function—as well as 
sensitive markers in plasma of effect on the 
thyroid. However, the study has a few weak-
nesses. First, several elements were highly 
correlated in both drinking water and urine 
(Concha et al. 2010); thus, it is not possible 
to account for potential confounding by other 
elements, particularly boron. Nevertheless, 
whereas lithium was associated with both T4 
and TSH, boron was associated with T4 only. 
To our knowledge, there are no data that show 
that boron is toxic to the thyroid; because little 
is known about the toxicology of boron, the 
possibility that boron may influence T4 cannot 
be excluded. In contrast, arsenic and cesium 
were not associated with TSH or T4. A second 
limitation is that we were not able to enroll a 
random sample of women, although we tried 
to recruit a representative population of the 
women living in this area. Finally, the cross-
sectional nature of the study limits our ability 
to determine temporal relations between lith-
ium exposures and the outcomes assessed. We 
believe that exposure levels would have been 
relatively stable over time, and that they would 
have begun very early in life. In support of this 
notion, the levels of lithium in drinking water, 
which contributes to a substantial fraction of 
the lithium in urine, have been stable during 
the period measured (2004–2008; Concha 
et al. 2010), and most of the women had lived 
in the area > 2 years.
Apart from our study, there are very 
few reports on the health effects of chronic 
lithium exposure besides the side effects of 
medication. In a recent study of suicide risk 
in relation to lithium concentrations in tap 
water in 18 municipalities of Oita prefecture 
in Japan, Ohgami et al. (2009) reported that 
the standardized mortality ratio for suicide 
was inversely associated with water lithium 
concentrations. In that study, water concen-
trations ranged from 0.7 to 59 μg/L, in con-
trast with a range from 8 to 1,005 μg/L in 
our study population (Concha et al. 2010). 
The Oita study has also been criticized for 
not considering lithium intake via food, 
which may reach > 100 μg/day (Desai and 
Chaturvedi 2009). In the present study, we 
estimated associations with urinary lithium 
concentrations, a biomarker of total exposure.
T4 was negatively correlated, and TSH 
weakly positively correlated with BMI. These 
associations may have been due to an effect 
of lithium on the thyroid, but we could not 
prove it statistically. In contrast with lithium, 
selenium was inversely associated with TSH 
and positively associated with T4. The pos-
sibility of an effect of selenium on thyroid 
function is consistently correlated with thy-
roid markers, which is in accordance with 
the proposed role of seleno  enzymes, includ-
ing deiodinase activities (Lu and Holmgren 
2009). However, because the deiodinases 
regulate the conversion of T4 to the thyroid 
hormone triiodo  thyronine (T3), we would 
expect selenium to be inversely associated 
with T4. Selenium is also present in seleno-
proteins such as gluta  thione peroxidase and 
the thio  redoxin reductase family, which are 
important for protection of the thyroid gland 
from excess hydrogen peroxide and reactive 
oxygen species produced by the follicles for 
bio  synthesis of thyroid hormones (Kohrle 
and Gartner 2009; Lu and Holmgren 2009; 
Prummel et al. 2004). We found no asso-
ciation between urinary iodine and the thy-
roid markers among the women in our study 
popu  lation, most of whom had adequate 
iodine status (WHO et al. 2007), with 62% 
having urinary concentrations > 100 μg/L. 
This suggests that the observed associations of 
lithium with markers of thyroid function were 
not due to confounding by low iodine con-
centrations. Because the iodine concentrations 
in this population were relatively high, we 
could not analyze the combined effect of high 
lithium and low iodine concentrations on 
thyroid function.
Further studies on geographic distribution 
of elevated lithium concentrations in drinking 
water, as well as studies of the effects of expo-
sure to lithium via drinking water and other 
environmental sources in women, men, and 
children, are highly warranted. The observed 
wide range of drinking water lithium concen-
trations among villages in the Puna region 
reinforces the need to screen all drinking water 
sources globally for many more potentially 
toxic elements than currently recommended.
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